Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pathology Holdings

Request full access

Anatomic pathology and molecular diagnostic testing services

Torrance, United StatesFounded 1979Biotech & Life Sciences

About Pathology Holdings

In 1979, the story of Pathology, Inc. began, establishing itself as a provider of anatomic pathology and molecular diagnostic testing services. The company focused on areas like women's health, offering a range of tests to help doctors personalize patient care. Over the years, it grew to become a premier laboratory on the West Coast, recognized for its expertise in various subspecialties of pathology. The narrative took a significant turn in 2016. Laboratory Corporation of America Holdings, better known as LabCorp, announced its acquisition of substantially all of Pathology, Inc.'s operating assets. This deal included Pathology, Inc.'s patient service centers and was seen as a move to enhance LabCorp's existing women's health services. For LabCorp, a major player in the healthcare diagnostics space, the acquisition represented an expansion of its geographic footprint and testing capabilities. A separate entity, Pathology Watch, entered the scene in 2017, founded in New York before relocating to Utah. This company aimed to modernize the traditional lab process by creating an integrated digital pathology platform, incorporating AI to improve efficiency and accuracy, particularly in dermatopathology. After securing Series A and B funding, Pathology Watch caught the attention of a global diagnostics powerhouse. In a strategic move to accelerate its own transition to digital pathology, Australia's Sonic Healthcare acquired Pathology Watch in a deal finalized in early 2024.

Source: Dealroom company data

At a glance

Status
Operational
Employees
166
Open positions
None listed
Dealroom signal
34.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Oct 2009 $25M $99M Undisclosed —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Pathology Holdings website traffic

Latest recorded traffic for Pathology Holdings is 0 monthly website visits. Pathology Holdings's team grew 2.5% over the past year.

Latest monthly visits0 1-year team growth+2.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Pathology Holdings in the Torrance ecosystem

Live from Dealroom

The Pathology Holdings office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States72.2%
🇮🇳 India19.4%
🇮🇷 Iran2.8%
🇹🇷 Turkey2.8%
🇧🇩 Bangladesh2.8%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pathology Holdings on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pathology Holdings’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.